591
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Results of renal artery revascularization in the post-ASTRAL era with 4 years mean follow-up

, , , , , , , , , & show all
Pages 285-290 | Received 15 Oct 2019, Accepted 09 Apr 2020, Published online: 02 May 2020

References

  • Gruntzig A, Kuhlmann U, Vetter W, et al. Treatment of renovascular hypertension with percutaneous transluminal dilatation of a renal-artery stenosis. Lancet. 1978;311(8068):801–802.
  • Wheatley K, Ives N, Gray R, et al.; ASTRAL Investigators. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361(20):1953–1962.
  • Cooper CJ, Murphy TP, Cutlip DE, et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med. 2014;370(1):13–22.
  • Aboyans V, Ricco JB, Bartelink ML, et al.; ESC Scientific Document Group. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS. Eur Heart J. 2018;39(9):763–816.
  • Anderson JL, Halperin JL, Albert NM, et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127(13):1425–1443.
  • Stevens LA, Coresh J, Feldman HI, et al. Evaluation of the modification of diet in renal disease study equation in a large diverse population. JASN. 2007;18(10):2749–2757.
  • Delin K. Renal hypertension. A clinical study of the use of renin measurements for preoperative diagnosis [dissertation]. Gothenburg: University of Gothenburg1982.
  • Jensen G, Annerstedt M, Klingenstierna H, et al. Survival and quality of life after renal angioplasty: a five-year follow-up study. Scand J Urol Nephrol. 2009;43(3):236–241.
  • Ribacke M, Tibblin G, Rosengren A, et al. Is hypertension changing? Blood pressure development in cohorts of 50-year-old men between 1963 and 1993. Blood Press. 1996;5(3):134–138.
  • Dahlöf B, Dahlöf Sever P, Poulter N, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366(9489):895–906.
  • Holmquist C, Hasselström J, Bengtsson Boström K, et al. Improved treatment and control of hypertension in Swedish primary care: results from the Swedish primary care cardiovascular database. J Hypertens. 2017;35(10):2102–2108.
  • Jaff MR, Bates M, Sullivan T, et al.; on behalf of the HERCULES Investigators. Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: results from the HERCULES trial. Cathet Cardiovasc Intervent. 2012;80(3):343–350.
  • Lederman RJ, Mendelsohn FO, Santos R, et al. Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am Heart J. 2001;142(2):314–323.
  • Zeller T, Frank U, Muller C, et al. Stent-supported angioplasty of severe atherosclerotic renal artery stenosis preserves renal function and improves blood pressure control: long-term results from a prospective registry of 456 lesions. J Endov Ther. 2004;11(2):95–106.
  • Prajapati JS, Jain SR, Joshi H, et al. Response of blood pressure after percutaneous transluminal renal artery angioplasty and stenting. WJC. 2013;5(7):247–253.
  • Laird JR, Rundback J, Zierler RE, et al. Safety and efficacy of renal artery stenting following suboptimal renal angioplasty for de novo and restenotic ostial lesions: results from a nonrandomized, prospective multicenter registry. J Vasc Interv Radiol. 2010;21(5):627–637.
  • Courand P-Y, Dinic M, Lorthioir A, et al. Resistant hypertension and atherosclerotic renal artery stenosis. effects of angioplasty on ambulatory blood pressure. Hypertension. 2019;74(6):1516–1523.
  • Plouin PF, Chatellier G, Darne B, et al. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension. 1998;31(3):823–829.
  • van Jaarsveld BC, Krijnen P. Prospective studies of diagnosis and intervention: the Dutch experience. Semin. Nephrol. 2000;20(5):463–473.
  • Mousa AY, AbuRahma AF, Bozzay J, et al. Update on intervention versus medical therapy for atherosclerotic renal artery stenosis. J Vasc Surg. 2015;61(6):1613–1623.
  • Rocha-Singh K, Jaff M, Rosenfield K. Evaluation of the safety and effectiveness of renal Artery stenting after unsuccessful balloon angioplasty: the ASPIRE-2 study. J Am Coll Cardiol. 2005;46(5):776–783.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.